Literature DB >> 18662989

Critical and distinct roles of p16 and telomerase in regulating the proliferative life span of normal human prostate epithelial progenitor cells.

Bobby Bhatia1, Ming Jiang, Mahipal Suraneni, Lubna Patrawala, Mark Badeaux, Robin Schneider-Broussard, Asha S Multani, Collene R Jeter, Tammy Calhoun-Davis, Limei Hu, Jianhua Hu, Spiridon Tsavachidis, Wei Zhang, Sandy Chang, Simon W Hayward, Dean G Tang.   

Abstract

Normal human prostate (NHP) epithelial cells undergo senescence in vitro and in vivo, but the underlying molecular mechanisms remain obscure. Here we show that the senescence of primary NHP cells, which are immunophenotyped as intermediate basal-like cells expressing progenitor cell markers CD44, alpha2beta1, p63, hTERT, and CK5/CK18, involves loss of telomerase expression, up-regulation of p16, and activation of p53. Using genetically defined manipulations of these three signaling pathways, we show that p16 is the primary determinant of the NHP cell proliferative capacity and that hTERT is required for unlimited proliferative life span. Hence, suppression of p16 significantly extends NHP cell life span, but both p16 inhibition and hTERT are required to immortalize NHP cells. Importantly, immortalized NHP cells retain expression of most progenitor markers, demonstrate gene expression profiles characteristic of proliferating progenitor cells, and possess multilineage differentiation potential generating functional prostatic glands. Our studies shed important light on the molecular mechanisms regulating the proliferative life span of NHP progenitor cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18662989      PMCID: PMC2562067          DOI: 10.1074/jbc.M803467200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

1.  Novel pathways associated with bypassing cellular senescence in human prostate epithelial cells.

Authors:  Steven R Schwarze; Samuel E DePrimo; Lisa M Grabert; Vivian X Fu; James D Brooks; David F Jarrard
Journal:  J Biol Chem       Date:  2002-02-08       Impact factor: 5.157

2.  Subcellular localization and tumor-suppressive functions of 15-lipoxygenase 2 (15-LOX2) and its splice variants.

Authors:  Bobby Bhatia; Carlos J Maldonado; Shaohua Tang; Dhyan Chandra; Russell D Klein; Dharam Chopra; Scott B Shappell; Peiying Yang; Robert A Newman; Dean G Tang
Journal:  J Biol Chem       Date:  2003-04-18       Impact factor: 5.157

3.  Heterogeneous methylation and deletion patterns of the INK4a/ARF locus within prostate carcinomas.

Authors:  Noboru Konishi; Mitsutoshi Nakamura; Munehiro Kishi; Masayoshi Nishimine; Eiwa Ishida; Keiji Shimada
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

4.  Cell differentiation lineage in the prostate.

Authors:  Y Wang; S Hayward; M Cao; K Thayer; G Cunha
Journal:  Differentiation       Date:  2001-10       Impact factor: 3.880

5.  Evidence that arachidonate 15-lipoxygenase 2 is a negative cell cycle regulator in normal prostate epithelial cells.

Authors:  Shaohua Tang; Bobby Bhatia; Carlos J Maldonado; Peiying Yang; Robert A Newman; Junwei Liu; Dhyan Chandra; Jeanine Traag; Russell D Klein; Susan M Fischer; Dharam Chopra; Jianjun Shen; Haiyen E Zhau; Leland W K Chung; Dean G Tang
Journal:  J Biol Chem       Date:  2002-02-11       Impact factor: 5.157

6.  Cellular senescence in the pathogenesis of benign prostatic hyperplasia.

Authors:  Patricia Castro; Dipak Giri; Dolores Lamb; Michael Ittmann
Journal:  Prostate       Date:  2003-04-01       Impact factor: 4.104

7.  Dissecting the contribution of p16(INK4A) and the Rb family to the Ras transformed phenotype.

Authors:  Philip J Mitchell; Elena Perez-Nadales; Denise S Malcolm; Alison C Lloyd
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

8.  A two-stage, p16(INK4A)- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status.

Authors:  James G Rheinwald; William C Hahn; Matthew R Ramsey; Jenny Y Wu; Zongyou Guo; Hensin Tsao; Michele De Luca; Caterina Catricalà; Kathleen M O'Toole
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

9.  An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo.

Authors:  Michael T Hemann; Jordan S Fridman; Jack T Zilfou; Eva Hernando; Patrick J Paddison; Carlos Cordon-Cardo; Gregory J Hannon; Scott W Lowe
Journal:  Nat Genet       Date:  2003-02-03       Impact factor: 38.330

10.  Identification and isolation of human prostate epithelial stem cells based on alpha(2)beta(1)-integrin expression.

Authors:  A T Collins; F K Habib; N J Maitland; D E Neal
Journal:  J Cell Sci       Date:  2001-11       Impact factor: 5.285

View more
  21 in total

1.  Rb-dependent cellular senescence, multinucleation and susceptibility to oncogenic transformation through PKC scaffolding by SSeCKS/AKAP12.

Authors:  Shin Akakura; Peter Nochajski; Lingqiu Gao; Paula Sotomayor; Sei-ichi Matsui; Irwin H Gelman
Journal:  Cell Cycle       Date:  2010-12-01       Impact factor: 4.534

2.  Functional remodeling of benign human prostatic tissues in vivo by spontaneously immortalized progenitor and intermediate cells.

Authors:  Ming Jiang; Douglas W Strand; Suzanne Fernandez; Yue He; Yajun Yi; Andreas Birbach; Qingchao Qiu; Johannes Schmid; Dean G Tang; Simon W Hayward
Journal:  Stem Cells       Date:  2010-02       Impact factor: 6.277

3.  Low p16INK4a Expression in Early Passage Human Prostate Basal Epithelial Cells Enables Immortalization by Telomerase Expression Alone.

Authors:  Mindy Kim Graham; Lorenzo Principessa; Lizamma Antony; Alan K Meeker; John T Isaacs
Journal:  Prostate       Date:  2016-11-08       Impact factor: 4.104

Review 4.  Tumor Dormancy and Slow-Cycling Cancer Cells.

Authors:  John E Davis; Jason Kirk; Yibing Ji; Dean G Tang
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

5.  Anti-tumor effect of 5-aza-2'-deoxycytidine by inhibiting telomerase activity in hepatocellular carcinoma cells.

Authors:  Shuang-Fen Tao; Chang-Song Zhang; Xian-Ling Guo; Yun Xu; Shan-Shan Zhang; Jian-Rui Song; Rong Li; Meng-Chao Wu; Li-Xin Wei
Journal:  World J Gastroenterol       Date:  2012-05-21       Impact factor: 5.742

6.  The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration.

Authors:  Jichao Qin; Xin Liu; Brian Laffin; Xin Chen; Grace Choy; Collene R Jeter; Tammy Calhoun-Davis; Hangwen Li; Ganesh S Palapattu; Shen Pang; Kevin Lin; Jiaoti Huang; Ivan Ivanov; Wei Li; Mahipal V Suraneni; Dean G Tang
Journal:  Cell Stem Cell       Date:  2012-05-04       Impact factor: 24.633

7.  Upregulated PPARG2 facilitates interaction with demethylated AKAP12 gene promoter and suppresses proliferation in prostate cancer.

Authors:  Feng Li; Tingting Lu; Dongmei Liu; Chong Zhang; Yonghui Zhang; Fulu Dong
Journal:  Cell Death Dis       Date:  2021-05-22       Impact factor: 8.469

8.  Transgenic expression of 15-lipoxygenase 2 (15-LOX2) in mouse prostate leads to hyperplasia and cell senescence.

Authors:  M V Suraneni; R Schneider-Broussard; J R Moore; T C Davis; C J Maldonado; H Li; R A Newman; D Kusewitt; J Hu; P Yang; D G Tang
Journal:  Oncogene       Date:  2010-05-31       Impact factor: 9.867

9.  Evaluating annotations of an Agilent expression chip suggests that many features cannot be interpreted.

Authors:  E Michael Gertz; Kundan Sengupta; Michael J Difilippantonio; Thomas Ried; Alejandro A Schäffer
Journal:  BMC Genomics       Date:  2009-11-30       Impact factor: 3.969

10.  Early human prostate adenocarcinomas harbor androgen-independent cancer cells.

Authors:  Rita R Fiñones; Jo Yeargin; Melissa Lee; Aman Preet Kaur; Clari Cheng; Paulina Sun; Christopher Wu; Catherine Nguyen; Jessica Wang-Rodriguez; April N Meyer; Stephen M Baird; Daniel J Donoghue; Martin Haas
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.